0001683168-21-004020.txt : 20210831 0001683168-21-004020.hdr.sgml : 20210831 20210831182503 ACCESSION NUMBER: 0001683168-21-004020 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210810 FILED AS OF DATE: 20210831 DATE AS OF CHANGE: 20210831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waggoner Kenneth L. CENTRAL INDEX KEY: 0001464611 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40699 FILM NUMBER: 211228161 MAIL ADDRESS: STREET 1: 8105 IRVINE CENTER DR. #820 CITY: IRVINE STATE: CA ZIP: 92618 FORMER NAME: FORMER CONFORMED NAME: Waggoner Kenneth DATE OF NAME CHANGE: 20090520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc. CENTRAL INDEX KEY: 0001157075 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621772151 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 BUSINESS PHONE: (917) 595.2850 MAIL ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 FORMER COMPANY: FORMER CONFORMED NAME: NUVILEX, INC. DATE OF NAME CHANGE: 20090324 FORMER COMPANY: FORMER CONFORMED NAME: EFOODSAFETY COM INC DATE OF NAME CHANGE: 20010808 3 1 ownership.xml X0206 3 2021-08-10 0 0001157075 PharmaCyte Biotech, Inc. PMCB 0001464611 Waggoner Kenneth L. 23046 AVENIDA DE LA CARLOTA SUITE 600 LAGUNA HILLS CA 92653 1 1 0 0 Chairman, CEO, Pres and GC Common Stock 20600 D Stock Option (right to buy) 156.00 2017-03-09 2022-03-09 Common Stock 3000 D Stock Option (right to buy) 83.70 2018-01-01 2023-01-01 Common Stock 3000 D Stock Option (right to buy) 74.25 2019-03-20 2024-03-20 Common Stock 3000 D Stock Option (right to buy) 61.20 2020-01-02 2025-01-01 Common Stock 3000 D Stock Option (right to buy) 10.05 2021-01-01 2025-12-31 Common Stock 3000 D The number of shares has been adjusted to reflect a one-for-1,500 reverse stock split of the Issuer's common stock effected on July 12, 2021 (the "Reverse Split"). The exercise price has been adjusted to reflect the Reverse Split. The option vested in twelve equal monthly installments beginning on January 1, 2021. /s/ Kenneth L. Waggoner 2021-08-31